1. The Forgotten Inhibitory Neurotransmitter

When discussions of neuro-inhibition and anxiety relief occur, GABA almost exclusively steals the scientific spotlight. Yet in the brainstem and spinal cord, an equally vital inhibitory neurotransmitter operates quietly: Glycine.

Glycine is the smallest of the 20 proteinogenic amino acids, consisting of a single carbon atom bonded to an amino group, a carboxyl group, and a hydrogen atom. Despite its diminutive chemical structure, glycine exerts monumental control over thermoregulation, motor tone, sleep latency, and neuroprotection.

2. The Thermoregulatory Mechanism: Dumping Core Heat

The primary reason millions of insomnia and anxiety sufferers cannot fall asleep is an inability to lower their core body temperature. In human circadian biology, the onset of sleep requires a drop in core temperature of 0.5°C to 1.0°C (1°F to 2°F). This drop is achieved not by sweating, but by peripheral vasodilation—opening the arteriovenous anastomoses in the palms of the hands, soles of the feet, and face to radiate central body heat into the ambient air.

Groundbreaking research conducted at the Ajinomoto Research Institute revealed how glycine unlocks this process:

3. GlyR Inhibitory Receptors in the Spinal Cord and Brainstem

Beyond hypothalamic thermoregulation, glycine binds to post-synaptic strychnine-sensitive glycine receptors (GlyRs). GlyRs are ligand-gated chloride ion channels composed of alpha and beta subunits.

When glycine binds to GlyRs:

4. The Landmark Clinical Evidence (Yamadera & Bannai Studies)

The clinical efficacy of glycine is established in human double-blind, placebo-controlled trials:

Study & Reference Sample & Methodology Key Findings & Objective Metrics
Yamadera et al. (2007)
Sleep & Biological Rhythms
Polysomnography (EEG) on volunteers with poor sleep; 3g glycine vs. placebo. Glycine significantly shortened sleep latency, increased slow-wave delta sleep (SWS), and stabilized sleep architecture with zero next-day daytime sleepiness.
Bannai et al. (2012)
Frontiers in Neurology
Sleep-restricted subjects evaluated for next-day daytime cognitive performance. 3g glycine prior to sleep prevented daytime cognitive decline, reduced subjective fatigue, and improved psychomotor vigilance test (PVT) reaction speeds.
Inagawa et al. (2006)
Sleep & Biological Rhythms
Subjective sleep quality questionnaires (VAS and SMH). Significant improvement in "satisfaction with sleep", "feeling refreshed on awakening", and reduction in morning grogginess compared to placebo.

5. Beyond Sleep: Glutathione, Collagen, and Hepatic Detox

Glycine's clinical utility extends far beyond sleep architecture:

6. Clinical Dosing and Synergistic Stacking

To replicate the clinical trials:

Frequently Asked Questions

Will taking glycine cause morning grogginess or dependence like sleeping pills?

No. Glycine does not act as a sedating hypnotic or allosteric GABAA modulator. Polysomnographic trials prove glycine leaves no residual hangover effect and has zero addiction or rebound withdrawal liability.

Can I get enough glycine from diet alone?

Most modern diets prioritize muscle meats (rich in methionine) and discard animal skins, bones, and cartilaginous cuts. The average human synthesizes only 3g of glycine and consumes 1.5–3g from diet, leaving an estimated 10g deficit relative to total metabolic requirements.

Is glycine safe for individuals taking prescription antidepressants?

Glycine is an endogenous amino acid with an exceptional safety profile up to 15–30g daily. However, because high doses can interact with NMDA receptor sites, individuals taking high-dose psychiatric medications should consult their physician before starting supplementation.